Why autism therapies have an evidence problem
Early interventions for autism lack solid data. The source of this problem is murky but may stem from ongoing debates about evidence quality and entrenched conflicts of interest within the field.
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
Early interventions for autism lack solid data. The source of this problem is murky but may stem from ongoing debates about evidence quality and entrenched conflicts of interest within the field.
The ability to conduct large-scale screening in human neurons could accelerate the discovery of autism treatments.
Without it, autistic adults with high support needs like my son are missing out on treatments that could reduce their suffering and improve their quality of life.
Targeting the molecule, 4EPS, with an experimental drug may be a way to ease anxiety for autistic people, the researchers say. But not everyone is convinced.
The Rett Syndrome Global Registry is gathering data from people around the world with the rare condition to support clinical trials.
Girls and young women with Rett syndrome have less severe anxiety and breathing problems after treatment with trofinetide, an analogue of insulin-like growth factor 1, according to an unpublished placebo-controlled trial.
Spectrum’s Autism Drug Tracker provides interactive, curated information about hundreds of clinical trials for autism and related conditions.
The tool provides interactive, curated information on more than 200 clinical trials for autism and related conditions.
Learn how to use the autism drug tracker, with specific examples and detailed explanations for each data column.